Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ADUS NASDAQ:AMED NYSE:CHE NASDAQ:LHCG NASDAQ:OPCH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeADUSAddus HomeCare$112.20-1.9%$112.34$88.96▼$136.72$2.11B0.81165,999 shs148,008 shsAMEDAmedisys$97.67-0.2%$95.81$82.15▼$98.95$3.21B0.94417,302 shs217,211 shsCHEChemed$466.26-1.1%$546.98$457.44▼$623.61$6.90B0.5112,399 shs132,820 shsLHCGLHC Group$169.81$166.14$115.32▼$169.84$5.27B0.43576,665 shsN/AOPCHOption Care Health$30.49-0.5%$31.86$21.39▼$35.53$5.02B0.731.86 million shs685,091 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceADUSAddus HomeCare+2.09%+3.66%-1.84%+12.42%-2.17%AMEDAmedisys+0.23%+2.01%+3.90%+6.98%+0.68%CHEChemed+1.26%+0.13%-14.01%-20.32%-10.54%LHCGLHC Group0.00%0.00%0.00%0.00%0.00%OPCHOption Care Health-0.68%-1.26%-3.25%-9.05%+13.57%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationADUSAddus HomeCare4.9233 of 5 stars2.65.00.05.03.42.53.1AMEDAmedisys2.6434 of 5 stars1.11.00.05.01.61.71.3CHEChemed4.9777 of 5 stars3.53.03.34.93.22.52.5LHCGLHC GroupN/AN/AN/AN/AN/AN/AN/AN/AOPCHOption Care Health4.3427 of 5 stars2.44.00.04.32.61.71.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceADUSAddus HomeCare 3.25Buy$142.5727.07% UpsideAMEDAmedisys 2.25Hold$100.753.15% UpsideCHEChemed 3.00Buy$645.0038.33% UpsideLHCGLHC Group 0.00N/AN/AN/AOPCHOption Care Health 2.88Moderate Buy$35.5016.43% UpsideCurrent Analyst Ratings BreakdownLatest AMED, LHCG, CHE, OPCH, and ADUS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/10/2025OPCHOption Care HealthBarrington ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$38.006/30/2025CHEChemedRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$674.00 ➝ $640.006/30/2025CHEChemedBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$708.00 ➝ $650.006/20/2025ADUSAddus HomeCareJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$150.006/18/2025OPCHOption Care HealthJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$36.006/10/2025ADUSAddus HomeCareMacquarieSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$133.005/8/2025ADUSAddus HomeCareMacquarieSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$129.00 ➝ $133.004/30/2025OPCHOption Care HealthBarrington ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$38.00 ➝ $38.004/30/2025OPCHOption Care HealthUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeNeutral ➝ Buy$38.00 ➝ $40.004/28/2025CHEChemedRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$667.00 ➝ $674.004/22/2025ADUSAddus HomeCareJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$150.00 ➝ $150.00(Data available from 7/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookADUSAddus HomeCare$1.15B1.79$5.28 per share21.23$53.52 per share2.10AMEDAmedisys$2.35B1.37$6.22 per share15.71$36.03 per share2.71CHEChemed$2.49B2.74$25.42 per share18.34$74.35 per share6.27LHCGLHC Group$2.22B2.37$7.51 per share22.60$52.17 per share3.25OPCHOption Care Health$5.00B1.00$1.64 per share18.63$8.25 per share3.70Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateADUSAddus HomeCare$73.60M$4.4325.3320.931.626.52%9.23%6.96%8/4/2025 (Estimated)AMEDAmedisys$43.23M$2.7136.0420.181.333.79%12.52%7.01%7/23/2025 (Estimated)CHEChemed$302M$20.5322.7120.012.2712.40%27.58%18.96%7/29/2025 (Estimated)LHCGLHC Group$115.73M$2.0582.8335.2322.732.73%8.13%4.63%N/AOPCHOption Care Health$211.82M$1.2424.5924.201.854.12%16.90%7.00%7/30/2025 (Estimated)Latest AMED, LHCG, CHE, OPCH, and ADUS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/4/2025Q2 2025ADUSAddus HomeCare$1.45N/AN/AN/A$345.71 millionN/A7/30/2025Q2 2025OPCHOption Care Health$0.40N/AN/AN/A$1.35 billionN/A7/23/2025Q2 2025AMEDAmedisys$1.39N/AN/AN/A$614.61 millionN/A7/23/2025Q2 2025CHEChemed$6.02N/AN/AN/A$650.60 millionN/A5/5/2025Q1 2025ADUSAddus HomeCare$1.33$1.42+$0.09$1.16$341.66 million$337.71 million4/29/2025Q1 2025OPCHOption Care Health$0.36$0.40+$0.04$0.28$1.26 billion$1.33 billion4/23/2025Q1 2025AMEDAmedisys$1.13$1.25+$0.12$1.84$597.43 million$594.78 million4/23/2025Q1 2025CHEChemed$5.59$5.63+$0.04$4.86$641.78 million$646.94 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthADUSAddus HomeCareN/AN/AN/AN/AN/AAMEDAmedisysN/AN/AN/AN/AN/ACHEChemed$2.000.43%N/A9.74%16 YearsLHCGLHC GroupN/AN/AN/AN/AN/AOPCHOption Care HealthN/AN/AN/AN/AN/ALatest AMED, LHCG, CHE, OPCH, and ADUS DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/20/2025CHEChemedquarterly$0.500.3%5/29/20255/29/20256/17/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioADUSAddus HomeCare0.201.741.74AMEDAmedisys0.271.291.29CHEChemedN/A1.731.70LHCGLHC Group0.441.451.45OPCHOption Care Health0.821.541.02Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipADUSAddus HomeCare95.35%AMEDAmedisys94.36%CHEChemed95.85%LHCGLHC Group83.47%OPCHOption Care Health98.05%Insider OwnershipCompanyInsider OwnershipADUSAddus HomeCare4.60%AMEDAmedisys2.10%CHEChemed3.29%LHCGLHC Group4.80%OPCHOption Care Health0.64%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableADUSAddus HomeCare49,70318.40 million17.55 millionOptionableAMEDAmedisys19,00032.82 million32.13 millionOptionableCHEChemed15,69514.63 million14.15 millionOptionableLHCGLHC Group30,00031.03 million29.54 millionOptionableOPCHOption Care Health8,088163.75 million162.70 millionOptionableAMED, LHCG, CHE, OPCH, and ADUS HeadlinesRecent News About These CompaniesOption Care Health (NASDAQ:OPCH) Earns "Outperform" Rating from Barrington ResearchJuly 10 at 2:36 PM | marketbeat.comOption Care Health, Inc. (NASDAQ:OPCH) Shares Bought by Bridges Investment Management Inc.July 10 at 7:25 AM | marketbeat.comPenserra Capital Management LLC Acquires Shares of 22,271 Option Care Health, Inc. (NASDAQ:OPCH)July 10 at 4:46 AM | marketbeat.comOPCH - Option Care Health Inc Chart - MorningstarJuly 8 at 9:19 AM | morningstar.comMTeacher Retirement System of Texas Has $3.76 Million Stock Position in Option Care Health, Inc. (NASDAQ:OPCH)July 8 at 4:05 AM | marketbeat.comCompass Wealth Management LLC Boosts Stake in Option Care Health, Inc. (NASDAQ:OPCH)July 6, 2025 | marketbeat.comOption Care Health, Inc. (NASDAQ:OPCH) Shares Sold by Leeward Investments LLC MAJuly 4, 2025 | marketbeat.comInvestors in Option Care Health (NASDAQ:OPCH) have seen impressive returns of 145% over the past five yearsJuly 3, 2025 | finance.yahoo.comOption Care Health Shows Improved Relative Strength; Still Shy Of BenchmarkJune 30, 2025 | msn.comAllspring Global Investments Holdings LLC Boosts Stake in Option Care Health, Inc. (NASDAQ:OPCH)June 30, 2025 | marketbeat.comOption Care Health (NASDAQ:OPCH) and Daxor (NASDAQ:DXR) Financial ReviewJune 30, 2025 | americanbankingnews.comOption Care Health, Inc. (NASDAQ:OPCH) Shares Sold by Villere ST Denis J & Co. LLCJune 28, 2025 | marketbeat.comOppenheimer Asset Management Inc. Increases Stock Holdings in Option Care Health, Inc. (NASDAQ:OPCH)June 28, 2025 | marketbeat.comBTSG vs. OPCH: Which Home Infusion Stock is a Better Buy Now?June 26, 2025 | zacks.comOption Care Health to Announce Second Quarter 2025 Financial Results and Host Conference CallJune 25, 2025 | globenewswire.comOption Care Health’s Q1 Earnings Call: Our Top 5 Analyst QuestionsJune 23, 2025 | finance.yahoo.comOption Care Health, Inc. (NASDAQ:OPCH) Shares Sold by Avior Wealth Management LLCJune 22, 2025 | marketbeat.comSG Americas Securities LLC Makes New Investment in Option Care Health, Inc. (NASDAQ:OPCH)June 21, 2025 | marketbeat.comRiverbridge Partners LLC Has $50.64 Million Stock Holdings in Option Care Health, Inc. (NASDAQ:OPCH)June 20, 2025 | marketbeat.comJanney Capital Management LLC Purchases New Position in Option Care Health, Inc. (NASDAQ:OPCH)June 20, 2025 | marketbeat.com1OPCH : Forecasting The Future: 5 Analyst Projections For Option Care HealthJune 18, 2025 | benzinga.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Catalysts in 7 Days: Archer's Growth Story Just AcceleratedBy Jeffrey Neal Johnson | June 18, 2025View 3 Catalysts in 7 Days: Archer's Growth Story Just AcceleratedAST SpaceMobile’s Star Is Rising: Get in While It’s Still Cheap!By Thomas Hughes | June 16, 2025View AST SpaceMobile’s Star Is Rising: Get in While It’s Still Cheap!NVIDIA’s Stock Price Hits New Highs: This Is What’s NextBy Thomas Hughes | June 26, 2025View NVIDIA’s Stock Price Hits New Highs: This Is What’s Next3 Tech Stocks With High and Rising Institutional InterestBy Thomas Hughes | June 19, 2025View 3 Tech Stocks With High and Rising Institutional InterestIBM Up 10 Days in a Row: What’s Driving the Winning Streak?By Dan Schmidt | June 13, 2025View IBM Up 10 Days in a Row: What’s Driving the Winning Streak?AMED, LHCG, CHE, OPCH, and ADUS Company DescriptionsAddus HomeCare NASDAQ:ADUS$112.20 -2.21 (-1.93%) Closing price 04:00 PM EasternExtended Trading$112.20 0.00 (0.00%) As of 06:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.Amedisys NASDAQ:AMED$97.67 -0.22 (-0.22%) Closing price 04:00 PM EasternExtended Trading$97.67 0.00 (0.00%) As of 06:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.Chemed NYSE:CHE$466.26 -5.31 (-1.13%) Closing price 03:59 PM EasternExtended Trading$467.77 +1.51 (+0.32%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.LHC Group NASDAQ:LHCGLHC Group, Inc. provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations. The Home Health segment offers a wide range of services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education. The Hospice Services segment offer a wide range of services, including pain and symptom management, emotional and spiritual support, inpatient and respite care, homemaker services, and counseling. The Home & Community-Based Services segment are performed by paraprofessional personnel, and include assistance to the elderly, chronically ill, and disabled patients with activities of daily living. The Facility Based Services segment includes long-term acute care hospitals treats patients with severe medical conditions who require a high-level of care and frequent monitoring by physicians and other clinical persoOption Care Health NASDAQ:OPCH$30.49 -0.15 (-0.49%) Closing price 04:00 PM EasternExtended Trading$30.51 +0.02 (+0.06%) As of 07:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Nebius Group: Up 385%, Analysts Say It’s Still a Bargain BigBear.ai: Why a 90% Rally Could Be Just the Start Will Oracle's Cloud and AI Deals Propel It to New Highs? Enovix Shares Hit 6-Month High; Long-Term Highs to Follow Tesla Stock Could Accelerate on New EV Tax Legislation SoundHound Rises as Short Sellers Exit and AI Demand Grows Alphabet: Technical Momentum Is Starting to Turn Boeing's Rebound Is Well Underway—But Is It Too Late? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
